Internal Medicine, Endocrinology, Diabetes, & Metabolism · Glendale, AZ
NPI
1417979907
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
20100 N 51st Ave, Suite F-635
Glendale, AZ, 85308
Phone (623) 266-7858
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,434 services
Medicare patients, 2024
402
Average age 73
Drug cost, 2024
$1.4M
6,670 prescriptions
Company payments, 2025
$158
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jasjeet Kaur was code 99214 (office e&m - established), 601 times for 271 patients. In total Jasjeet Kaur billed 1,434 services in 10 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 601 | 271 | $87.71 | $53K |
| 76536 Ultrasound - Nonspecific | Office | 314 | 247 | $76.18 | $24K |
| 99213 Office E&M - Established | Office | 240 | 184 | $55.44 | $13K |
| 95251 Test - Miscellaneous | Office | 193 | 77 | $24.61 | $4,750 |
| 99204 Office E&M - New | Office | 51 | 51 | $120.92 | $6,167 |
| 95250 Test - Miscellaneous | Office | 16 | 15 | $97.47 | $1,559 |
By year: 2022 $129K for 1,717 services; 2023 $122K for 1,683 services; 2024 $104K for 1,434 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jasjeet Kaur prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,910 prescriptions and refills. In total Jasjeet Kaur wrote 6,670 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,910 | 3,966 | 385 | $14K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 453 | 763 | 110 | $72K |
| Humalog Kwikpen U-100 Insulin Lispro | 342 | 482 | 77 | $118K |
| Metformin Hcl Generic | 337 | 592 | 75 | $2,041 |
| Glipizide Generic | 252 | 459 | 62 | $1,990 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 246 | 332 | 57 | $88K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 204 | 301 | 62 | $19K |
| Jardiance Empagliflozin | 197 | 303 | 39 | $178K |
| Synthroid Levothyroxine Sodium | 185 | 354 | 37 | $11K |
| Methimazole Generic | 180 | 243 | 35 | $1,659 |
| Calcitriol Generic | 169 | 300 | 32 | $6,315 |
| Novolog Flexpen Insulin Aspart | 163 | 246 | 49 | $51K |
| Glipizide Er Glipizide | 135 | 261 | 24 | $1,505 |
| Januvia Sitagliptin Phosphate | 126 | 189 | 25 | $104K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 95 | 151 | 25 | $18K |
Brand drugs: 3,654 claims; generic drugs: 2,277 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jasjeet Kaur $158 ($158 in general payments such as food, travel and fees) from 4 companies. The largest payer was Dexcom, Inc. with $103.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.